Investigation of fluctuations in immunosuppression in connection with complications after kidney transplantation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00033736

Enrollment

600

Registered

2024-03-25

Start date

2024-03-25

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Z94.0

Interventions

Group 1: Kidney transplant recipients with a transplant date between 01.01.2010 and 31.12.2021 Primary outcome measures: (1) Association of intrapatient variability of tacrolimus (TacIPV) at month 3-6

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Kidney transplant recipients (de-novo or re-transplanted) - Age =18 years

Exclusion criteria

Exclusion criteria: - Failure to meet the above inclusion criteria - Insufficient documentation available

Design outcomes

Primary

Measure	Time frame
de novo donor-specific antibodies >6 months post-transplant	—

Secondary

Measure	Time frame
biopsy-proven rejection >6 months post-transplant	—

Countries

Germany

Contacts

Public ContactLouise Benning

Nierenzentrum Heidelberg

louise.benning@med.uni-heidelberg.de+49622191120

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026